410,000 customers in west virginia didn t have power as of last night. ohio, 400,000 folks in ohio without. 340,000 in virginia, same deal there. power authorities and local governments say many of those people might be in the dark until this weekend. those people are going to have to deal with more soaring temperatures, 12 states under heat advisories this morning and the heat wave is forecast to last all week long. sandra endo is live in arlington, virginia, looks a bit of a mess behind you there. do people there have electricity? i m guessing not. reporter: not in this neighborhood, brook, it s been four days since the violent storm swept through this region. you can still see the devastation left behind. the power lines have downed because these toppled trees ripped the power lines from the tell phone poles and crushing car and struing debris about. this violent storm swept through this neighborhood. this area is without power as are tens of thousands of people sufferin
only 22% of studies are actually making it there. the problem is, i actually focus usually on media reports and i say that headline doesn t show the real story then i read the actual study. it turns out the actual study may not show the real story because it may not have all the individual data with we need. this study in the british medical journal looked back and found unless you have everything, the whole method section, knowing what each patient went through, you may miss whether the drug was helpful or harmful. you may miss it was more helpful than you thought. we heard of many stories with the diabetes drug avandia, the drug for the spinal cord, a heart drug where there was a big delay that s a biggest problem, there s a big delay for the real information gets out. gregg: when i open a medical journal occasionally all these advertisements are there could that influence
actually making it there. the problem is, i actually focus usually on media reports and i say that headline doesn t show the real story then i read the actual study. it turns out the actual study may not show the real story because it may not have all the individual data with we need. this study in the british medical journal looked back and found unless you have everything, the whole method section, knowing what each patient went through, you may miss whether the drug was helpful or harmful. you may miss it was more helpful than you thought. we heard of many stories with the diabetes drug avandia, the drug for the spinal cord, a heart drug where there was a big delay that s a biggest problem, there s a big delay for the real information gets out. gregg: when i open a medical journal occasionally all these advertisements are there could that influence nobody is going to admit that, but that s a big
client dollars last week and tried to avoid detection as it did so. so now the fbi is on the case. the former new jersey governor jon corzine is mf global s chairman and ceo. there is word that he could take home a severance package worth more than $12 million. but, actually, once the bankruptcy happened, the severance package went out the door. but the $350,000 he was given to help negotiate his contract, well, that s water under the bridge. the pharmaceutical giant glaxo smith klein will pay the feds $3 billion to settle a 14 year legal battle with the department of justice over some of its best selling drugs. it s reportedly the largest pharmaceutical settlement in united states history. the feds accuse the company of illegally marketing and developing such meds as the antidepressant paxil and more recently the diabetes drug avandia. the feds restricted the sale after researchers linked it to tens of thousands of heart attacks.
a senate investigator found the folks at glaxo knew that avandia s risks were high for years and withheld important data from the food and drug investigation. trace gallagher is live from our west coast news hub this afternoon. how does this effect patients. the hope is we will all be getting the right medicines for the right illnesses. one of the biggest accusations against glaxo smith klein is they were getting drugs from the f.d.a. and using and marketing those drugs for different purposes. in other words, you get something approved by the f.d.a. for heart disease and promote to treat diabetes and then you push or you pay the doctors to prescribe it for diabetes. listen. as a physician i can decide that i want to use a drug for an off label use. that s very different than a drug company promoting it for me for that using when is disingenuous if the f.d.a. hasn t come to the same conclusion. so glaxo says to keep the drugs from being used for